CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
BETHESDA, Md., May 4, 2016 -- The Bladder Cancer Advocacy Network is pleased to announce the appointment of Andrea Maddox-Smith as Chief Executive Officer, effective May 2.
Maddox-Smith is an innovative and energetic leader with extensive experience in non-profit management, program development and fundraising. Prior to joining BCAN, Maddox-Smith served in a variety of leadership roles at the American Diabetes Association for 16 years, most recently as the senior vice president, Eastern division/nationwide mission delivery. In this role, she oversaw all aspects of operations management, new business development, staff management and volunteer recruitment.
"We are thrilled to have Andrea on board," said Diane Zipursky Quale, co-Founder of BCAN. "We know that she will inspire the bladder cancer community and marshal the people and resources necessary to collaboratively implement BCAN's mission and ensure the organization's continued growth and impact."
The new leadership comes at a critical time in the organization's history with the recent introduction of the Bladder Cancer Genomics Consortium. A collaboration with BCAN and major medical institutions, the consortium is designed to increase research to improve outcomes for bladder cancer patients.
"I strive to create a sense of urgency around this disease that would allow every newly diagnosed bladder cancer patient access to BCAN resources," said Maddox-Smith. "I am excited to bring a progressive and results oriented approach and vision to the organization by collaborating with the many volunteers, researchers, clinicians and members."
About the Bladder Cancer Advocacy Network
The Bladder Cancer Advocacy Network's mission is to increase public awareness about bladder cancer, advance bladder cancer research, and provide educational and support services for the bladder cancer community. BCAN serves as the leading voice for bladder cancer in the U.S., providing resources to not only those diagnosed with the disease but their families, caregivers and the medical community united in support of people impacted by the disease. The organization is setting the agenda for bladder cancer by promoting and funding collaborative and cutting-edge research programs and providing critical patient support and education services. BCAN works collaboratively with the medical and research professionals dedicated to the prevention, diagnosis, and treatment of bladder cancer, and empowers the patient community by allowing them to share experiences with others and to participate in building awareness of the need for a cure. For more information go to www.bcan.org or call 1-888-901-BCAN (2226).
CONTACT: Natalie Bennett
Email: [email protected]
Phone: 301.215.9099 ext 202
